Mergers & Acquisitions
By The Online Investor Staff, updated Thu., Mar. 28, 5:12 AM
Slide #11. APx Acquisition Corp. I — OmnigenicsAI Corp and MultiplAI Health Ltd
Acquirer: |
APx Acquisition Corp. I (NASDAQ:APXI) |
Acquiree: |
OmnigenicsAI Corp and MultiplAI Health Ltd |
Details: |
APx Acquisition Corp. I (NASDAQ: APXI) ("APx"), a publicly traded special purpose acquisition company, OmnigenicsAI Corp ("OmnigenicsAI"), a precision medicine company incubated by Bioceres Group PLC, and MultiplAI Health Ltd ("MultiplAI"), a UK-based AI-enabled preventive medicine company, have entered into a definitive Business Combination Agreement ("BCA") that, upon closing, would result in OmnigenicsAI becoming a publicly listed company. The transaction is expected to close mid-year, subject to the approval of APx's shareholders and other customary closing conditions and, upon closing, OmnigenicsAI's shares are expected to be listed on Nasdaq under the ticker symbol "OMNI". |
APx Acquisition is a blank check company formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses.
Open the APXI Page at The Online Investor »
Open the APXI Page at The Online Investor (in a new window) »
|
March 28, 2024 5:12 AM Eastern
|